Cycle-specific and cumulative fecundity in patients with endometriosis who are undergoing controlled ovarian hyperstimulation-intrauterine insemination or in vitro fertilization-embryo transfer

被引:105
|
作者
Dmowski, WP [1 ]
Pry, M [1 ]
Ding, JC [1 ]
Rana, N [1 ]
机构
[1] Inst Study & Treatment Endometriosis, Oak Brook, IL USA
关键词
endometriosis; infertility; fecundity; pregnancy; COH-IUI; IVF-ET;
D O I
10.1016/S0015-0282(02)03343-5
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To compare controlled ovarian hyperstimulation-intrauterine insemination (COH-IUI) or IVF-ET pregnancy rates per cycle (PR) and cycle and cumulative fecundity (f and cf) with COH-IUI or IVF-ET in endometriosis. Design: Retrospective analysis. Setting: Endometriosis research institute. Patient(s): Women with endometriosis and infertility (n = 313) who underwent consecutive COH-IUI (202 patients, 648 cycles), IVF-ET (111 patients, 139 cycles), or IVF-ET after failed COH-IUI (56 patients, 68 cycles). Intervention(s): None. Main Outcome Measure(s): Crude PR and life table-estimated f and cf. Result(s): With COH-IUI, 69 patients conceived 65 conceived with IVF-ET and 30 conceived with IVF-ET after COH-IUI (PR 11%, 47%, and 44%). With COH-IUI, six-cycle cf was 41%, and f for cycles 1-6 was 15%, 12%, 8%, 7%, 7%, and 0. With IVF-ET, three-cycle cf was 73%, whereas f for cycles 1-3 was 47%, 27%, and 33%. First-cycle f with IVF-ET was significantly higher than cf of six COH-IUI cycles. When die data were stratified according to the stage of endometriosis and women's age, the benefit of IVF over COH was even more pronounced. Prior COH-IUI failure did not adversely affect IVF-ET outcome. Conclusion(s): In endometriosis, PR, f, and cf are significantly higher with IVF-ET than COH-IUI, especially in stage IV and in women >38 years of age. Considering, adverse effects of prolonged ovarian stimulation on endometriosis, IVF-ET should be the first-line approach in the management of infertility in this disease. If COH-IUI is attempted, it should not exceed three to four cycles.
引用
收藏
页码:750 / 756
页数:7
相关论文
共 50 条
  • [41] The effect of prolonged GnRH agonist (GnRHa) therapy on in vitro fertilization-embryo transfer (IVF-ET) cycle outcome in endometriosis (ENDO) patients: a multicenter randomized trial.
    Surrey, ES
    Silverberg, KM
    Surrey, MW
    Schoolcraft, WB
    FERTILITY AND STERILITY, 2001, 76 (03) : S151 - S151
  • [42] Clinical efficacy of the gonadotropin-releasing hormone antagonist, ganirelix, in Korean women undergoing controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer with recombinant follicle-stimulating hormone
    Moon, SY
    Ku, SY
    Kim, SM
    Jee, BC
    Suh, CS
    Choi, YM
    Kim, JG
    Kim, SH
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2005, 31 (03) : 227 - 235
  • [43] Prediction of ovarian reserve based on day-3 serum follicle stimulating hormone concentrations during the pituitary suppression cycle using a gonadotropin releasing hormone agonist in patients undergoing in vitro fertilization-embryo transfer
    Onagawa, T
    Shibahara, H
    Ayustawati
    Machida, S
    Hirano, Y
    Hirashima, C
    Takamizawa, S
    Suzuki, M
    GYNECOLOGICAL ENDOCRINOLOGY, 2004, 18 (06) : 335 - 340
  • [44] Prospective evaluation of basal stromal Doppler studies in women with good ovarian reserve and infertility undergoing in vitro fertilization-embryo transfer treatment: patients with polycystic ovary syndrome versus ovulatory patients
    Younis, Johnny S.
    Jadaon, Jimmy E.
    Haddad, Sami
    Izhaki, Ido
    Ben-Ami, Moshe
    FERTILITY AND STERILITY, 2011, 95 (05) : 1754 - 1758
  • [45] Clinical outcomes following long GnRHa ovarian stimulation with highly purified human menopausal gonadotropin plus rFSH or rFSH in patients undergoing in vitro fertilization-embryo transfer: a multi-center randomized controlled trial
    Shu, Li
    Xu, Qianhua
    Meng, Qingxia
    Dai, Xue
    Zhang, Yun
    Zhou, Wei
    Yi, Honggang
    Liu, Jinyong
    Wu, Chunxiang
    Hou, Zhen
    Cui, Yugui
    Li, Tin Chiu
    Liu, Jiayin
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (07)
  • [46] A randomized, assessor-blind, multicentre study to investigate the efficacy and efficiency of a starting dose of 100IU or 200IU of recombinant follicle stimulating hormone (Puregon®) in women undergoing controlled ovarian hyperstimulation for in vitro fertilization-embryo transfer treatment.
    Tan, SL
    Child, TJ
    Cheung, P
    Fluker, M
    Casper, R
    Davis, V
    FERTILITY AND STERILITY, 2003, 80 : S185 - S185
  • [47] A study to determine the efficacy of controlled ovarian hyperstimulation regimen using a gonadotropin releasing hormone agonist versus antagonist in women of advanced reproductive age with varying degrees of oocyte reserve on outcome following in vitro fertilization-embryo transfer
    Check, J. H.
    Choe, J. K.
    Cohen, R.
    Wilson, C.
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2013, 40 (02): : 191 - 192
  • [48] Triggering ovulation with leuprolide acetate (LA) instead of human chorionic gonadotropin (hCG) after the use of ganirelix for in vitro fertilization-embryo transfer (IVF-ET) does not compromise cycle outcome and may prevent ovarian hyperstimulation syndrome
    Bracero, NJ
    Jurema, MW
    Posada, MN
    Whelan, JG
    Garcia, JE
    Vlahos, NP
    FERTILITY AND STERILITY, 2001, 76 (03) : S93 - S93
  • [49] The usefulness of peri-trigger female reproductive hormones (delta-FRH) in predicting oocyte maturation in normal ovarian reserve patients who received in vitro fertilization-embryo transfer: a retrospective study
    He, Lina
    Xu, Qing
    Wan, Fuming
    Hao, Li
    Qiu, Yamin
    Ran, Xu
    Lin, Jie
    Chen, Wei
    PEERJ, 2024, 12
  • [50] Efficacy and safety of Dingkun pill for female infertility patients with low prognosis undergoing in vitro fertilization-embryo transfer: study protocol for a multicenter, double-blind, randomized, placebo-controlled trial
    Song, Jingyan
    Ma, Ting
    Liang, Yanlin
    Cao, Xianling
    Sun, Zhengao
    TRIALS, 2020, 21 (01)